Reaction Assisted Coating (PIRAC) produces a stable layer on their surface. We have examined the ability of the new TiN coating to undergo osseointegration. We implanted TiN-coated and uncoated Ti6Al4V alloy pins into the femora of six-month-old female Wistar rats.
corrosion resistance, high fatigue strength and low elastic modulus which reduces stress shielding. [2] [3] [4] [5] In regard to abrasive and adhesive wear, however, titanium and Ti6Al4V appear to be inferior to other surgical alloys. [5] [6] [7] [8] If an orthopaedic device is subjected to relative sliding at the Ti6Al4V-metal or Ti6Al4V-polyethylene interface there is damage to the passivating surface oxide, with the generation of particulate metal and polyethylene debris and enhanced release of metal ions. [5] [6] [7] [8] [9] [10] [11] This wear debris is responsible for the commonly observed blackening of adjacent tissues and is accompanied by the mobilisation of macrophages leading to osteolysis and aseptic loosening of the implant. [11] [12] [13] [14] [15] [16] [17] [18] Thus, the more widespread use of Ti and its alloys in orthopaedics, especially as articulating components of total joint replacements, depends on our ability to modify their surface chemistry and microstructure. Various surface modifications have been used for improving the wear and corrosion behaviour of Ti alloys. The most commonly used are ultrapassivation of titanium and implantation of nitrogen ions. 1, 4, [18] [19] [20] [21] The latter has become a standard procedure for Ti alloys but it cannot guarantee adequate resistance to wear of the critical components of total joint replacements or of long-term service because of the rapid thinning of the hardened layer, which is about 0.5 m thick. [21] [22] [23] A variety of ceramic coatings has been tested and used for improving the properties of the metal surface and enhancing bone ingrowth. 24, 25 Lately, there has been an increasing interest in using titanium nitride (TiN) coating to improve the wear properties of Ti6Al4V. It has a high hardness and low friction coefficient, and has been shown to be efficient in reducing the wear of cutting tools. TiN coating is biologically inert and has been approved by the Federal Food and Drug Administration for use in titanium and the components of titanium alloy implants. In several experiments in vitro, TiN-coated implants were shown to have decreased polyethylene and metal wear when compared with other materials used for prostheses. 26, 27 Physical vapour deposition (PVD) is the most common method of depositing TiN on orthopaedic implants. In PVD, TiN is formed by the reaction of pure Ti and nitrogen gas in a vapour phase before deposition, which leads to poor bonding integrity of the substrate and coating. 28 As a result, delamination has been observed in wear simulation tests in vitro and in clinical studies. 29, 30 To prevent the failure of adhesion of the TiN, methods of modifying the surface to provide strong bonding at the TiN coatingsubstrate interface have been studied. Recently, an original PIRAC (Powder Immersion Reaction Assisted Coating) method of application of nitride has been proposed for the coating of Ti alloy parts of complex shape. 31 In this method, TiN coating several microns thick is formed by the interaction of a Ti-based substrate with highly reactive monatomic nitrogen. Since the substrate is directly involved in the process of the formation of the coating, TiN PIRAC coating is similar to oxide films on metals and alloys, and is characterised by an excellent conformity and strong adhesion to the substrate. TiN PIRAC coating on Ti6Al4V has been reported to contain no toxic Al and V ions and to improve the fretting behaviour of Ti6Al4V alloy. 31 We have tested the behaviour of the PIRAC TiN coating by implanting TiN-coated and uncoated Ti6Al4V alloy pins into the femora of adult rats.
Materials and Methods
TiN coating and implant preparation. Cylindrical rods, 1 mm in diameter and 2 cm long, were cut from Ti6Al4V alloy wire. A TiN coating 3 m thick was applied using the PIRAC method. 31 Briefly, the rods were annealed under a low pressure of monatomic nitrogen provided by selective diffusion of atmospheric nitrogen through the walls of the reaction chamber at 900°C. Both coated and uncoated implants were cleaned by vigorous shaking in 2% Triton X-100 (Aldrich Inc, Milwaukee, Wisconsin), washed in running tap water, rinsed in several changes of phosphate-buffered saline and autoclaved. Operative procedure. We used 20 six-month-old female Wistar rats weighing approximately 300 g. They were housed in standard plastic cages, three per cage, at 22°C with a 12-hour light-dark cycle. The animals were anaesthetised using a mixture of 50 mg/kg body-weight of ketamine HC1 (Ketaset; Fort Dodge Animal Health, Fort Dodge, Iowa) and 10 mg/kg of xylazine (Rompun, Bayer, Germany) injected intraperitoneally. An incision 2 cm long was made on the medial side of the knee and, after pushing the patella aside, a hole was drilled with a 21G injection needle from the intercondylar notch through the spongy bone of the distal epiphysis. TiNcoated and uncoated implants were inserted into the left and right femoral medullary canal, respectively (Fig. 1) . The fasciae and skin were sutured separately and no external bandages were applied. Each animal was given a single dose of 10 mg/kg body-weight of gentamicin (Vitamed, Bat Yam, Israel). They recovered quickly from surgery and were allowed full movement and weight-bearing immediately after.
Two months after implantation the rats were killed by an overdose of ketamine. Three days before killing, oxytetracycline (30 mg/kg/body-weight) (Vetimex, Bladel, Holland) was injected intraperitoneally. Radiographs (Model D-50M; Bennett, New York) were taken at 75 kV, 150 mA/s immediately after surgery and before killing to confirm the position of the implant and to check for fractures. We measured the body-weight before surgery and when killed; the means and standard deviation (SD) were calculated. We used the unpaired Student t-test for comparisons using Instat Graphpad Software (San Diego, California). SEM, electron-probe microanalysis (EPMA) and image analysis. The femora were excised, cleaned of soft tissues, fixed in 10% neutral buffered formaldehyde for three weeks and embedded, undecalcified, in LKB Historesin (LKB, Bromma, Sweden). Transverse sections, 300 m thick, were cut using a low-speed diamond saw. The sections were coated with gold and examined by scanning electron microscopy (SEM) (JEOL, Tokyo, Japan). We performed EPMA analyses on representative sections.
We carried out image analysis on SEM negatives using the Olympus Image Analysis System (Lake Success, New York) with Cue-4 morphometry software. The system consists of a light box, a Nikon micro Nikkor 55 mm lens attached to a Sony CCD video camera (XC-57), a Sony monitor and an IBM-compatible computer. The implant- bone contact was estimated as a percentage of the circumference of the implant in contact with the bone. The area of bone (mm 2 ) was measured within a 0.3 mm wide ring drawn around the implant, after manually excluding bone marrow from the image (Fig. 2) . The volume of bone was calculated as the percentage of the area of the ring occupied by bone. Measurements were performed on specimens from five animals, three sections from each femur, and the means and standard error of the mean (SEM) were calculated. The paired Student t-test was used for statistical comparisons using Instat Graphpad Software. Fluorescent oxytetracycline labelling. Three sections from each specimen were examined and photographed using an inverted microscope with fluoroscence optics (Zeiss ICM405, Oberkochen, Germany). Histochemistry. Specimens from five animals were demineralised in Tris-HC1 buffered 10% EDTA in 0.05M Tris-HC1 buffer (pH 7.2) for three weeks at 4°C. The implants were carefully removed and the demineralised specimens frozen in liquid nitrogen and stored at -30°C. The specimens were serially sectioned in the coronal plane at 10 m using a cryostat microtome (Lipshaw, Detroit, Michigan). Sections were mounted on poly-L-lysine-coated microscope slides (SuperFrost Plus; Menzel Glasser, Braunschweig, Germany) and stored at -30°C until the enzymic activities had been determined. We measured alkaline phosphatase (ALP) by the azo-dye coupling method. 32 Freshly prepared incubation medium consisted of 25 mg of ␣-naphthyl phosphate disodium salt (Sigma, St Louis, Missouri) and 25 mg of Fast Violet B salt (Sigma) in 25 ml of 0.05M Tris-HC1 buffer (pH 10.5) containing 0.025M MgC1 2 . Sections were incubated for seven minutes at 37°C, rinsed in reaction buffer, postfixed for 15 minutes in aqueous 10% paraformaldehyde and mounted with glycerol-gelatin (Sigma). Tartrate-resistant acid phosphatase (TRAP) was determined by the azo-dye coupling method 32 modified according to Minkin. 33 The incubation medium consisted of ␣-naphthyl phosphate and Fast Violet B dissolved in 25 ml of 0.05M Na acetate buffer (pH 5) containing 0.05M sodium tartrate (Sigma). Sections were incubated for 60 minutes at 37°C, rinsed in reaction buffer, postfixed and mounted as above.
Non-specific esterase (NSE) was determined by the azodye coupling method. 32 The incubation medium consisted of 5 mg of naphthol AS-MX acetate (Sigma) dissolved in 0.5 ml of dimethyl formamide and 40 mg of Fast Blue BB salt (Sigma) in 25 ml of 0.1M sodium phosphate buffer (pH 7.1) containing 0.25 ml of propylene glycol. Sections were incubated for 120 minutes at 25°C, rinsed in reaction buffer, postfixed and mounted as above.
Results
The body-weight of the animals increased non-significantly during the experimental period, from 317 ± 23 (SD) g at implantation to 331 ± 39 (SD) g after two months (t-test; n = 20; mean difference 14.0; 95% confidence interval of the difference -6.5 to 34.5; p = 0.175).
Radiological findings. Figure 1 shows that the implants cross the distal head of femur into the medullary cavity. The bent end of the implant protrudes into the cavity of the joint but the animals had no difficulty in using their limbs and a full range of movement was observed. Similar radiographs taken at the end of the experiments indicated no change in the position of the implants. Scanning electron microscopy. Photomicrographs of cross-sections of femora two months after implantation are shown in Figure 3 . Bone sockets have formed around both TiN-coated (Fig. 3a) and uncoated (Fig. 3b) implants. Close contact was observed between the bone layer and the surface of the implant. To confirm that the socket is indeed bone, SEM-EPMA was performed at three sites in the vicinity of the implant (Fig. 3a) . Typical EPMA spectra are shown in Figure 4 . In the bone marrow ( Fig. 3a-1 ) only two peaks were detected, those of carbon (C) and oxygen (O), the signal of C being much stronger than that of O (Fig.  4a) . In the EPMA spectrum of the tissue which appears as mature bone (Fig. 3a-2 ), strong calcium (Ca) and phosphorus (P) signals were detected. Also, the signal of O became much stronger than that of C, as expected from the presence of hydroxyapatite (Fig. 4b) . For the tissue near the implant which appeared as fibrous tissue (Fig. 3a-3) , the EPMA spectrum is intermediate between bone and soft tissue (Fig. 4c) . This suggests that the tissue is osteoid undergoing mineralisation. Morphometrical analyses revealed no significant differences between the percentage of implant-bone contact, bone area and bone volume around the TiN-coated and uncoated implants (Table I) with both TiN-coated (Fig. 5a ) and uncoated (Fig. 5b) implants. The bone more distant to the implants showed significantly weaker labelling with oxytetracycline. Histochemistry. Bone remodelling in the area of the implant was assessed by histochemical determination of ALP and TRAP activities in frozen sections. Strong ALP activity was observed in the bone layer surrounding both TiN-coated and uncoated implants (Fig. 6) . Only a few TRAP-positive cells were seen in the area (Fig. 7) . Similarly, only a few NSE-positive cells were observed near the implants. Some macrophages were seen in the bone marrow (Fig. 8) .
Discussion
Although the issue of cemented versus cementless total hip replacement is still controversial, the latter is favoured by some surgeons for younger and active patients. 34, 35 At present, Ti6Al4V alloy seems to be the most suitable material for cementless prostheses, mainly because of its lower modulus of elasticity as compared with CoCrMo alloy. [1] [2] [3] Titanium is biologically inert and has a high corrosion resistance due to the spontaneous formation of a film of titanium oxide (TiO 2 ) on its surface.
1,2,4,36 Titanium is also characterised by an excellent capacity for osseointegration. 1, 37, 38 TiO 2 appears to play a central role in the osseointegration of titanium-based implants, and direct chemical bonding between the bone tissue and TiO 2 has been postulated. 1, 36, 39 Titanium and its alloys have been used successfully for osseous dental implants, but the cementless titanium alloy prostheses have been less satisfactory. [5] [6] [7] 12 The TiO 2 film is prone to destruction when subjected to the shearing forces acting on functional ortho- paedic implants. This can induce separation of the implant from the bone and enhance metal ion release and the formation of wear particles, leading eventually to aseptic loosening of the prosthesis. TiN has the potential to provide a mechanically stable coating, and thus to improve titanium wear and chemical resistance. TiN coatings, commonly applied by PVD, were reported to have an excellent resistance to wear in simulator tests in vitro. 26, 27 Although clinical experience with TiN-coated femoral implants is limited, loosening because of delamination and fretting of the coating has been reported. 29, 30 In contrast to PVD coatings which are bound to the substrate by weak secondary bonds, in the PIRAC method the substrate is directly involved in the formation of the coating, resulting in its excellent adhesion. 31 In our study we tested the new coatings in vivo with emphasis on their ability to undergo osseointegration. Endosseous implants can be fixed by direct implant-bone integration or by a fibrous layer interposed between the surface of the bone and the implant. The presence of fibrous tissue at the implant-bone interface has been reported in most implant failures. 1, 5, 14, 17, 18, 40 Our SEM findings showed that PIRAC TiN-coated implants behaved in a way similar to uncoated implants and underwent osseointegration in the femora of adult rats. Moreover, as can be judged from the low number of macrophages demonstrated by NSE activity, the implants did not evoke adverse tissue reactions.
For cementless implants a period of immobilisation is recommended for maximal osseointegration, since early movement may cause the formation of a fibrous membrane. 1, 7, 38, 39, 42 In our study, animals were allowed full movement and weight-bearing immediately after surgery and were quite active during the experimental period. We cannot establish the degree of movement or stress acting upon the implants, but since the end of the pin protruded into the cavity of the knee, some movement probably occurred. Since the bone collar which encapsulated the implant was connected to the cortex of the femur and the trabeculae of epiphyses, transfer of stress was possible. Nevertheless, both the TiN-coated and uncoated implants were integrated with bone, with implant-bone contact of over 85%.
